Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesPhysical Medicine, Rehab & TherapiesAetna FES NMES Coverage & Prior Auth Policy Update…
    Ask Trek AI about this page

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    CurrentAetnaPolicy 0677

    Functional Electrical Stimulation and Neuromuscular Electrical Stimulation

    Customize your policy alerts

    Sign up for Aetna Policy 0677 alerts

    Get alerted when Policy 0677 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Defines Aetna's medical necessity, experimental/investigational determinations, limitations/exclusions, and covered CPT/HCPCS/ICD-10 codes for FES and NMES devices and related implanted stimulators (including diaphragmatic/phrenic pacing, sacral anterior root stimulation, Vocare Bladder System, Remede System, form-fitting conductive garments, wearable NMES devices).

    Policy Summary
    PayerAetna
    PolicyFunctional Electrical Stimulation and Neuromuscular Electrical Stimulation
    Policy CodePolicy 0677
    Change TypeNo material change
    Effective DateFeb 6, 2004
    Last ReviewFeb 27, 2024
    Next Review DateJul 25, 2024
    Key ActionProviders must document that ALL FES selection criteria are met (including intact lower motor units, completion of ≥32 PT sessions over 3 months, ability to stand 3 minutes, and absence of listed contraindications) to support coverage for Parastep I System.
    SourceLink
    POLICY UPDATE CHANGES

    No material changes — this policy brief indicates has_material_change=false and lists no policy update items.

    9Medically necessary indications listed
    32Required FES training sessions
    2NMES max hours/day
    ~1000Estimated phrenic pacing implants
    88DPS implants in FDA trials
    15+Experimental/Investigational items

    Coverage Summary & Scope

    Coverage summary: Aetna's policy takes a mixed stance: several FES/NMES and implantable stimulation interventions are covered when specific selection criteria and documentation requirements are met, while many other uses are considered experimental/investigational. Status: CURRENT (effective 2004-02-06; last review 2024-02-27; next review 2024-07-25). Headline thresholds: FES ambulation (Parastep I) requires completion of at least 32 PT training sessions over 3 months and the ability to stand ≥3 minutes; NMES daily usage limited to ≤ 2 hours per 24-hour period; Vocare (sacral anterior root) timing is ≥ 3 months (female) or ≥ 9 months (male) after complete supra-sacral SCI with specified cystometry pressure thresholds; diaphragmatic pacing requires ability to breathe ≥ 4 continuous hours/day without mechanical ventilator assistance when used for ventilatory improvement. Detailed CPT/HCPCS/ICD-10 groups and coverage conditions are enumerated in the policy for each covered indication.

    Quick thresholds & facts
    FES training sessionsAt least 32 physical therapy sessions over a 3-month period
    FES standing abilityMember can transfer independently and stand for at least 3 minutes
    NMES daily usageNo more than 2 hours per 24-hour period (more than 2 hours not medically necessary)
    Policy Summary
    PayerAetna
    PolicyFunctional Electrical Stimulation and Neuromuscular Electrical Stimulation
    Policy CodePolicy 0677
    Change TypeNo material change
    Effective DateFeb 6, 2004
    Last ReviewFeb 27, 2024
    Next Review DateJul 25, 2024
    Key ActionProviders must document that ALL FES selection criteria are met (including intact lower motor units, completion of ≥32 PT sessions over 3 months, ability to stand 3 minutes, and absence of listed contraindications) to support coverage for Parastep I System.
    SourceLink
    On This Page
    Coverage Summary & ScopeDetailed Medical Necessity CriteriaExperimental, Investigational, and Not Medically Necessary InterventionsCoding GuidancePrior Authorization, Documentation & Billing RulesClinical Background & Evidence OverviewDefinitionsMedicare DeterminationsRevision History
    Estimated phrenic/diaphragmatic pacing implants worldwideApproximately 1,000 people have received phrenic pacing devices
    DPS FDA trial implants (2000-2007)88 patients implanted in FDA multi-center trials

    Detailed Medical Necessity Criteria

    Experimental, Investigational, and Not Medically Necessary Interventions

    Experimental / Investigational (Not Medically Necessary)

    Aetna considers the following interventions experimental and investigational (not medically necessary) because effectiveness has not been established:

    FES of the upper extremities (e.g., NESS H200 Handmaster NMS1 System) for all indications, including improvement of muscle strength, reduction of spasticity and atrophy, and facilitation of functional motor movement due to spinal cord injury, stroke (cerebrovascular accident/CVA), traumatic brain injury, or other upper motor neuron disorders (e.g., Parkinson's disease).
    FES and NMES for all other indications not listed as medically necessary, including but not limited to: Bell's palsy; cardiac conditioning; cerebral palsy; chronic obstructive pulmonary disease; congestive heart failure; erectile dysfunction; foot drop in cerebral palsy, stroke, and other indications; general muscle strengthening in healthy individuals; improving ambulatory function and muscle strength for progressive diseases (e.g., cancer, chronic heart failure, chronic obstructive pulmonary disease, multiple sclerosis) in persons without spinal cord injury; improvement of functional capacity and quality of life after cardiac surgery; masseter muscle oral dysfunction after stroke; muscle atrophy after stroke; pain caused by necrosis of the femoral head; treatment of denervated muscles; treatment of knee osteoarthritis; upper extremity hemiplegia.
    Wearable NMES devices (e.g., geko T-3 and geko W-3) for enhancement of blood circulation/microcirculation, reduction of edema, and prevention of venous thrombosis in the lower limb with venous insufficiency and/or ischemia.
    Diaphragmatic/phrenic pacing for indications other than those listed as medically necessary (including use in individuals whose phrenic nerve, lung or diaphragm function are insufficient to achieve adequate diaphragm movement from electrical stimulation, and improved outcomes in lung transplant recipients).
    Sacral nerve stimulation for treatment of chronic constipation.
    Transurethral electrical stimulation for management of neurogenic bladder dysfunction and all other indications.
    Peroneal nerve stimulators and other devices/indications not listed as medically necessary.
    Not Covered HCPCS / Other CodesHCPCSNot Covered
    A4595Electrode, non-fixed, any type, per pair
    E0745Neuromuscular stimulator, electronic shock unit
    E0766Transcutaneous electrical nerve stimulator (TENS) device for use with chronic pain
    Experimental HCPCS / Other CodesHCPCSExperimental
    E1399Durable medical equipment, miscellaneous
    Not Covered ICD-10 CodesICD-10Not Covered
    S14.0XXAInjury of nerves and spinal cord at neck level, initial encounter
    S14.159AOther and unspecified injuries of nerves and spinal cord at neck level, initial encounter
    S24.0XXAInjury of nerves and spinal cord at thorax level, initial encounter
    S24.159AOther and unspecified injuries of nerves and spinal cord at thorax level, initial encounter
    S34.01XInjury of nerve root at lumbosacral plexus level
    S34.129AOther specified injuries of spinal cord at lumbosacral level, initial encounter
    S12.000AFracture of cervical vertebra, unspecified, initial encounter
    S12.391AOther fracture of C3-C7 vertebra, initial encounter
    S14.101AInjury of nerve root of neck, initial encounter
    S14.154AInjury of other specified nerve of neck, initial encounter
    1–10 of 25
    1/3

    Coding Guidance

    Covered CPT codes (FES for spinal cord injury when selection criteria met)CPTCovered
    63655Laminectomy for implantation of neurostimulator electrodes, plate/paddle, epidural.
    63685Insertion or replacement of spinal neurostimulator pulse generator or receiver, direct or inductive coupling.
    64555Percutaneous implantation of neurostimulator electrodes; peripheral nerve (excludes sacral nerve).
    64575Incision for implantation of neurostimulator electrodes; peripheral nerve (excludes sacral nerve).
    64585Revision or removal of peripheral neurostimulator electrodes.
    64590Insertion or replacement of peripheral or gastric neurostimulator pulse generator or receiver, direct or inductive coupling.
    64595Revision or removal of peripheral or gastric neurostimulator pulse generator or receiver.
    Other CPT codes neutralCPT
    33016-33999Heart and pericardium (range referenced).
    Covered HCPCS codes (FES/NMES supplies and systems)HCPCSCovered
    A4556Electrodes (e.g., apnea monitor), per pair.
    A4557Lead wires (e.g., apnea monitor), per pair.
    A4558Conductive gel or paste, for use with electrical device (e.g., TENS, NMES), per oz.
    A4595Electrical stimulator supplies, 2 lead, per month (e.g., TENS, NMES).
    E0731Form-fitting conductive garment for delivery of TENS or NMES (with conductive fibers separated from the patient's skin by layers of fabric).
    E0745Neuromuscular stimulator, electronic shock unit.
    E0762Transcutaneous electrical joint stimulation device system, includes all accessories.
    E0764Functional neuromuscular stimulator, transcutaneous stimulation of muscles of ambulation with computer control, used for walking by spinal cord injured, entire system, after completion of training program.
    E0770Functional electrical stimulator, transcutaneous stimulation of nerve and/or muscle groups, any type, complete system, not otherwise specified.
    L8680Implantable neurostimulator electrode, each.
    1–10 of 18
    1/2
    Covered CPT codes (NMES)CPTCovered
    64550Application of surface (transcutaneous) neurostimulator.
    64565Percutaneous implantation of neurostimulator electrodes; neuromuscular.
    64580Incision for implantation of neurostimulator electrodes; neuromuscular.
    Diaphragmatic/phrenic pacing CPT codes (covered when criteria met)CPTCovered
    33277Insertion of phrenic nerve stimulator transvenous sensing lead.
    33278Removal of phrenic nerve stimulator, including vessel catheterization, imaging guidance, interrogation and programming; system including pulse generator and lead(s).
    33279Transvenous stimulation or sensing lead(s) only.
    33280Pulse generator only.
    33281Repositioning of phrenic nerve stimulator transvenous lead(s).
    33287Removal and replacement of phrenic nerve stimulator; pulse generator.
    33288Transvenous stimulation or sensing lead(s).
    64580Incision for implantation of neurostimulator electrodes; neuromuscular.
    93150Therapy activation of implanted phrenic nerve stimulator system, including interrogation and programming.
    93151Interrogation and programming (minimum one parameter) of implanted phrenic nerve stimulator system.
    1–10 of 11
    1/2
    Remede System (central sleep apnea) CPT/HCPCS (covered when criteria met)mixedCovered
    0424T-0427TInsertion or replacement of neurostimulator system for treatment of central sleep apnea (T-codes range).
    C1823Generator, neurostimulator (implantable), non-rechargeable, with transvenous sensing and stimulation leads.
    Covered CPT codes (Electrical stimulation of sacral anterior roots)CPTCovered
    63185Laminectomy with rhizotomy; one or two segments.
    63190Laminectomy with rhizotomy; more than two segments.
    63655Laminectomy for implantation of neurostimulator electrodes, plate/paddle, epidural.
    64561Percutaneous implantation of neurostimulator electrode array; sacral nerve (transforaminal placement) including image guidance, if performed.
    64581Incision for implantation of neurostimulator electrode array; sacral nerve (transforaminal placement).
    HCPCS related to sacral anterior roots (covered when criteria met)HCPCSCovered
    A4290Sacral nerve stimulation test lead, each.
    E0745Neuromuscular stimulator, electronic shock unit.
    L8680Implantable neurostimulator electrode, each.
    L8681Patient programmer (external) for use with implantable programmable neurostimulator pulse generator.
    L8682Implantable neurostimulator radiofrequency receiver.
    L8684Radiofrequency transmitter (external) for use with implantable sacral root neurostimulator receiver for bowel and bladder management, replacement.
    L8685Implantable neurostimulator pulse generator, single array, rechargeable, includes extension.
    L8686Implantable neurostimulator pulse generator, single array, non-rechargeable, includes extension.
    L8687Implantable neurostimulator pulse generator, dual array, rechargeable, includes extension.
    L8688Implantable neurostimulator pulse generator, dual array, non-rechargeable, includes extension.
    1–10 of 11
    1/2
    Form-fitting conductive garment HCPCS (covered when criteria met)HCPCSCovered
    E0731Form-fitting conductive garment for delivery of TENS or NMES (with conductive fibers separated from the patient's skin by layers of fabric).

    Billing and authorization constraints: providers must document that ALL applicable selection criteria are met to obtain prior authorization for FES/NMES implantable systems (examples include codes E0764, E0770, 63655, 64555 for Parastep I and similar systems). Replacement of implanted FES or diaphragmatic/phrenic systems requires documentation that the original device met medical necessity and is no longer under warranty (codes such as E0764, E0745, L8685/L8686). NMES for disuse atrophy requires documentation of intact nerve supply and non-neurological cause plus prior failure of physical therapy when required (billable codes include 64550, E0745, A4595). Billing rule: do not bill for more than 2 hours of NMES within any 24-hour period (codes commonly involved include A4595, E0745). Many device and supply HCPCS/CPT groups (implantable leads/generators, functional stimulator systems, and supply codes) are listed in the policy as commonly subject to prior authorization/documentation requirements.

    Prior Authorization, Documentation & Billing Rules

    Prior Authorization

    Medical necessity documentation for FES

    Providers must document that ALL FES selection criteria are met to support coverage for Parastep I System. Required documentation should confirm intact lower motor units (L1 and below), successful completion of a training program of at least 32 physical therapy sessions over a 3-month period, the member’s ability to transfer independently and stand for at least 3 minutes, and absence of any listed contraindications (cardiac pacemaker, severe scoliosis or severe osteoporosis, skin disease or cancer at stimulation site, irreversible contracture, autonomic dysreflexia). Affected codes: E0764, E0770, 63655, 64555.

    • Affected codes: E0764, E0770, 63655, 64555
    • Document intact lower motor units (L1 and below)
    • Document completion of ≥32 PT training sessions with device over a 3-month period
    • Document ability to transfer independently and stand ≥3 minutes
    • Document absence of contraindications listed (pacemaker; severe scoliosis or osteoporosis; skin disease/cancer at stimulation site; irreversible contracture; autonomic dysreflexia)
    Prior Authorization

    Replacement authorization

    Replacement of implanted FES or diaphragmatic/phrenic stimulation systems requires documentation that the original device met medical necessity criteria and that the original device is no longer under warranty and cannot be repaired. Affected codes include E0764, E0745, L8685, L8686.

    • Affected codes: E0764, E0745, L8685, L8686
    • Document original device met applicable medical necessity criteria
    • Document device is no longer under warranty and is not repairable
    Documentation Required

    NMES for disuse atrophy

    For NMES to treat disuse atrophy, document that the nerve supply to the target muscle is intact and that a specific non‑neurological reason for disuse atrophy is present (e.g., contracture from burn scarring, major knee surgery with PT failure, prior casting/splinting with PT failure, or recent hip replacement prior to PT). Where required, document prior failure to respond to physical therapy.

    • Affected codes: 64550, E0745, A4595
    • Document intact nerve supply to the muscle
    • Document the non-neurological cause of disuse atrophy
    • Document prior failure to respond to physical therapy when applicable
    Billing Rule

    NMES daily usage limit

    Billing for NMES supplies/devices should reflect that more than 2 hours of NMES within a 24‑hour period is considered not medically necessary. Providers should not bill for NMES use exceeding this threshold.

    • Affected codes: A4595, E0745
    • Usage threshold: ≤ 2 hours per 24‑hour period; >2 hours/24 hr is not medically necessary
    Documentation Required

    Vocare Bladder System selection documentation

    Document patient selection criteria for the Vocare Bladder System (sacral anterior root stimulation with posterior rhizotomy): ASIA classification indicating clinically complete supra‑sacral lesion with intact parasympathetic innervation of the bladder; timing since injury (≥3 months for females, ≥9 months for males after complete supra‑sacral SCI); cystometry demonstrating a phasic detrusor pressure rise meeting thresholds (≥35 mm H2O female, ≥50 cm H2O male); and presence of at least 3 of 4 non‑vesical sacral segment reflexes (ankle jerks, bulbo‑cavernous reflex, anal skin reflex, reflex erection).

    • Affected codes: 63185, 63190, 64561
    • Document ASIA classification and clinically complete supra‑sacral lesion with intact parasympathetic innervation
    • Document timing since injury: ≥3 months (female) or ≥9 months (male)
    • Document cystometry detrusor pressure thresholds: ≥35 mm H2O (female) or ≥50 cm H2O (male)
    • Document presence of ≥3 of 4 non‑vesical sacral reflexes (ankle jerks, bulbo‑cavernous, anal skin reflex, reflex erection)
    Prior Authorization

    Remede System prior therapy failure

    Prior to coverage for the Remede System (phrenic nerve stimulation for central sleep apnea), document that the patient has failed supplemental oxygen therapy, pharmacotherapy (e.g., acetazolamide or theophylline), and mask‑based therapies such as CPAP or BiPAP.

    • Affected codes: 0424T-0427T, C1823
    • Document failure of supplemental oxygen therapy
    • Document failure of pharmacotherapy (e.g., acetazolamide, theophylline)
    • Document failure of mask-based therapies (CPAP, BiPAP)
    Documentation Required

    Diaphragmatic pacing candidate evaluation

    Document evaluation of candidacy for diaphragmatic (phrenic) pacing: evidence of viable phrenic nerves, adequate diaphragm and lung function, and that the patient is stable and out of the acute phase. Mapping (motor point mapping) and intraoperative testing/mapping are recommended as part of the evaluation and implantation process.

    • Viability requirements: viable phrenic nerves and diaphragm movement with stimulation
    • Adequate diaphragm and lung function to permit at least 4 continuous hours off mechanical ventilation when indicated
    • Patient stability: out of the acute phase of injury
    • Recommendation: laparoscopic motor point mapping and intraoperative mapping/testing prior to implantation
    Documentation Required

    Vocare/Brindley patient selection and testing

    Before implantation of Vocare/Brindley systems, perform pre‑implant cystometry and reflex testing to assess bladder emptying potential. Success criteria post‑implant are defined as the ability to void more than 200 ml on demand with post‑void residual (PVR) <50 ml.

    • Affected codes: 63185, 63190, 64561
    • Perform pre-implant cystometry to assess detrusor contractility
    • Assess non‑vesical sacral reflexes (require presence of 3 of 4)
    • Success thresholds: ability to void >200 ml on demand and PVR <50 ml post‑implant

    Clinical Background & Evidence Overview

    Background (brief): Spinal cord injury (SCI) severity is classified by the ASIA Impairment Scale (A–E) based on motor and sensory function including sacral segments; SCI may involve upper motor neuron (UMN) and/or lower motor neuron (LMN) damage, with implications for responsiveness to electrical stimulation. FES (a form of NMES) delivers patterned electrical impulses to motor nerves to generate functional movements; the Parastep I System is a transcutaneous, micro-computerized FES system controlled from a walker hand-bar that triggers peripheral nerves to enable standing and short-distance ambulation. Evidence and experience show variable ambulatory benefit: training programs (at least 32 sessions) can enable standing and short ambulation with high inter-individual variability and reports of many users achieving at least 30 feet of ambulation. Distinctions: members must have intact lower motor units and peripheral nerve–muscle connectivity (L1 and below) for FES ambulation candidacy, unlike UMN-predominant impairments where some FES applications may be less effective. Other FES applications described include diaphragmatic/phrenic pacing (implantation of electrodes on phrenic nerves and implanted stimulator to condition and stimulate the diaphragm) for ventilator-dependent SCI, central alveolar hypoventilation, and selected ALS patients — requiring viable phrenic nerves, adequate diaphragm/lung function, and ability to achieve at least 4 continuous hours/day of ventilator-independent breathing — and sacral anterior root stimulation (Vocare/Brindley) with posterior rhizotomy for selected complete supra-sacral SCI patients meeting timing and cystometry/reflex thresholds for restoration of voiding on demand.

    Study / SourceKey finding / metric
    Klose et al (1997) — Parastep I training study32 training sessions enabled standing and short-distance ambulation in thoracic motor-complete SCI; high inter-individual variability
    Graupe & Kohn (1998) — Parastep I usage seriesReported ~400 users; essentially all achieved standing and ≥30 ft ambulation (some up to 1 mile)
    Onders et al — DPS multi-center experience (2000–2007)88 implanted (50 SCI, 38 ALS); 96% SCI patients replaced mechanical ventilation; no perioperative mortality reported
    Remede System pivotal RCT (Costanzo et al., Lancet 2016)RCT n=151: 51% treatment vs 11% control achieved ≥50% AHI reduction at 6 months; 91% had no related serious AEs at 12 months
    Meta-analyses of FES for foot drop in MS (Miller et al. 2017; Springer 2017)Meta-analysis (19 studies, 490 pts): short-walk orthotic effect +0.05–0.08 m/s; no therapeutic effect on long-walk tests
    FES vs AFO RCTs (Sheffler 2006; Kluding 2013; Everaert 2013; Bethoux 2014)Multiple RCTs show FES often equivalent to AFO for gait speed and function; sometimes higher user satisfaction with FES
    NMES in COPD (Maddocks et al. 2017; Chen et al. 2016)RCT (n=52): 6-week 6MWT +29.9 m vs placebo −5.7 m (MD 35.7 m, p=0.005); meta-analysis (9 trials, n=276) showed improved quadriceps strength (SMD 1.12) and exercise distance (WMD ~51.5 m)
    Knee rehabilitation (Kneehab vs Polystim) — Feil et al. 2011Kneehab group: extensor strength +27.8–30.2% at 6 months; single-leg hop +50% between 6wk–6mo; significant Lysholm improvement vs control/Polystim
    Stroke NMES/FES evidence syntheses (Pereira 2012; Eraifej 2017)Pooled RCTs (chronic stroke) small but significant effect on 6MWT (SMD 0.379; p=0.013); upper-limb FES evidence low-quality/heterogeneous
    NMES for post-stroke dysphagia (Wang 2023 meta-analysis)46 RCTs (3,346 pts): NMES + standard therapy improved multiple swallowing measures (e.g., PAS MD −0.63; FOIS MD +1.32); safety/long-term data limited

    Definitions

    TermDefinition
    ASIA Impairment ScaleClassification system describing extent of spinal cord injury from A (complete) to E (normal) based on motor and sensory function including sacral segments S4-S5.
    Diaphragmatic/phrenic pacing (DPS)Surgically implanted electrodes on phrenic nerves connected to an implanted stimulator to condition and stimulate the diaphragm for ventilatory support.
    Transurethral electrical bladder stimulation (TEBS)A procedure involving bladder filling and transurethral electrode stimulation intended to restore detrusor contractility via repeated sessions.
    NESS H200 / HandmasterUpper extremity neuroprosthesis that applies surface electrical stimulation via a custom orthosis to produce functional hand movements.
    TEBSTransurethral electrical bladder stimulation
    NMESNeuromuscular electrical stimulation — electrical stimulation to elicit muscle contraction for training/rehabilitation.
    FESFunctional electrical stimulation — device-based application of electrical stimulation to restore or produce functional movements.
    AFOAnkle-foot orthosis — an orthotic device for ankle/foot support.
    Threshold Electrical Stimulation (TES)Low-intensity electrical stimulation, usually at night, intended to strengthen muscles weakened by non-use and increase joint mobility.
    FES (functional) — duplicate termApplication of electrical stimulation to motor nerves to generate muscle contractions to produce functional movements (e.g., for foot drop).
    NMES (neuromuscular) — duplicate termSurface or implanted electrical stimulation applied to muscles to produce contraction for strengthening or re-education.
    SNS/SNMSacral nerve stimulation / sacral neuromodulation — implantable stimulation of sacral nerve roots for fecal incontinence/constipation and related pelvic disorders.
    PNSPhrenic nerve stimulation — stimulation of phrenic nerve/diaphragm for central sleep apnea or ventilator weaning.
    DPDiaphragm pacing — implantation of intramuscular electrodes in hemi-diaphragm for stimulation to restore diaphragmatic function.
    TAPSTranscutaneous afferent patterned stimulation — patterned peripheral nerve stimulation therapy used by Cala Trio for essential tremor.
    gekoWearable NMES devices (T-3, W-3) that stimulate common peroneal nerve to activate calf muscle pump for enhanced blood flow.
    Functional Electrical Stimulation (general) — definitionApplication of electrical current to produce functional movement, e.g., to correct foot drop.
    Neuromuscular Electrical Stimulation (general) — definitionApplication of electrical stimulation to elicit muscle contraction, often for strengthening, pain, or rehabilitation.
    Transcutaneous afferent patterned stimulation (full)Noninvasive, wrist-worn neuromodulation targeting median and radial sensory afferents at tremor frequency to reduce essential tremor.
    Phrenic nerve stimulation (alternative label)Synonymous with diaphragmatic/phrenic pacing; stimulation of phrenic nerve/diaphragm for central sleep apnea or ventilator weaning.
    Neuromuscular electrical stimulation — alternate phrasingSurface or implanted stimulation to elicit muscle contraction for strengthening, re-education, or functional assistance.
    Functional neuromuscular stimulator (device class)Devices for transcutaneous stimulation of muscles of ambulation with computer control (e.g., Parastep/other FES ambulation systems).

    Medicare Determinations

    No results

    Revision History

    2004-02-06effective

    Policy effective date (Functional Electrical Stimulation and Neuromuscular Electrical Stimulation).

    2024-02-27last_reviewLatest

    Policy last review date.